VERU INC. Other Restructuring Costs
VERU INC. (VERU) reported Other Restructuring Costs of $1.93 million for the 12-month period ending 2010-09-30, per its 10-K filed 2012-12-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2012-12-04
- VERU INC. other restructuring costs for the quarter ending 2010-09-30 was $3.48K.
- VERU INC. other restructuring costs for the quarter ending 2010-06-30 was -$41.66K.
- VERU INC. other restructuring costs for fiscal 2010 was $1.93M, a 28.95% increase from fiscal 2009.
- VERU INC. other restructuring costs for fiscal 2009 was $1.50M.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month |
|---|---|---|---|---|
| 2010-09-30 | $3.48K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | -$38.18K derived: sum of 2 quarters · filed 2012-12-04 | $1.93M 10-K · filed 2012-12-04 | |
| 2010-06-30 | -$41.66K 10-Q · filed 2011-08-05 | $1.93M 10-Q · filed 2011-08-05 | ||
| 2009-09-30 | $1.50M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |